Eye care products are called back. In a broad consumer safety notice, several eye care items are being recalled throughout the United States. The recall, which was issued by BRS Analytical Service, LLC, was prompted after serious issues were discovered during a recent FDA inspection. Today, we will explore why eye care products were called back, and what should you do during this call back?
Why This Recall Matters
The recall is being done at the consumer level, meaning it impacts day-to-day users. These are items that are typically used to treat dry eyes, irritation, and other day-to-day eye problems.
But the FDA audit found that the company did not adhere to current Good Manufacturing Practices (cGMP). These are critical guidelines ensuring the safety and quality of medicines. Non-compliance with these standards may lead to contamination, instability, or other problems that directly threaten user health.
Which Products Are Affected?
Some very common products are involved in the recall. Each of those was shipped throughout the U.S. from May 26, 2023, to April 21, 2025. The affected products are as follows:
- Artificial Tears Ophthalmic Solution (NDC# 50268-043-15)
- Carboxymethylcellulose Sodium Ophthalmic Gel 1% (NDC# 50268-066-15)
- Carboxymethylcellulose Sodium Ophthalmic Solution (NDC# 50268-068-15)
- Lubricant Eye Drops Solution (NDC# 50268-126-15)
- Polyvinyl Alcohol Ophthalmic Solution (NDC# 50268-678-15)
These eye drops and gels are often sold over-the-counter in pharmacies and used without medical supervision. That makes this recall even more critical.
What Should Consumers Do?
Stop using these products immediately. Discontinue use whether or not you’ve experienced symptoms. The manufacturer advises all customers to check the National Drug Code (NDC) numbers on their packaging.
If you possess the product, complete the “Quantity to Return” and Customer Information fields on the recall notice. Subsequently, send the completed form either by fax at 931-292-6229 or by e-mail at customerservice@avkare.com.
Even if you’ve dispossessed yourself of the product already, the company still asks that you report your purchase and return the recall notice form. It assists in tracking distribution and avoiding further danger.
What Are the Risks?
Although no certain health problems have yet been widely reported in association with these items, poor manufacture is a number of issues. Eye care items, particularly sterilized ones, have to ensure high standards of safety. In the event of these standards being breached, the product can:
- Cause eye infection
- Result in blurred vision
- Cause irritation or allergic responses
- Possibly cause existing eye complaints to worsen
This is especially risky to those with pre-existing sensitive eyes or weakened immunity.
Industry Responsibility
This recall is a harsh reminder of the importance of FDA compliance. The cGMP regulations exist not only to shield firms from legal issues, but to safeguard consumers from injury. When a firm skimps on quality or misses tight controls, the consequences can be severe.
BRS Analytical Service, LLC’s voluntary decision to recall products is a welcome move. But now the concern has to lie with public education and prevention.
What’s Next?
In case you’ve had any undesirable reaction following use of these eye care products, report it at once to your healthcare provider. You can even lodge a complaint with the FDA’s MedWatch Safety Information and Adverse Event Reporting Program. Hence, be attentive and take necessary action to save your families and yourself from the unhealthy foods.
Conclusion
All in all, consumer safety begins with awareness. If you or someone you know wears artificial tears or any type of over-the-counter eye drops, take a moment to double-check the label. A quick glance could save you from a severe health scare.
Stay alert, stay informed, and take care of your eyes.
